As India's drug-regulator approved two COVID-19 vaccines on Sunday, several concerns have emerged regarding the availability of the vaccines to the general people. To answer the questions, the health ministry shared a three-part video on social media, addressing all queries related to the vaccine
Here are all the queries answered by All India Institute of Medical Sciences (AIIMS) director Dr Randeep Guleria.
Yes, vaccine trials are underway and they are on different stages on finalisation. Many vaccines are undergoing phase 3 trials and they are about to be completed. The government is ready to launch the vaccine once the regulatory board gives nod to them.
This wholly depends on the availability of the vaccine. Based on risk factors, the government has set priority groups. The first group includes frontline healthcare workers, the second group includes people above age 50 along with those under 50 with the comorbid condition.
Since the availability of the vaccine is based on a priority list, taking the vaccine is voluntary. In order to protect ourselves, everyone it advised to take the complete schedule of the vaccine.
Two doses of vaccine have to be taken 28 days apart.
Generally, two weeks after the second dose of the vaccine, the protecting antibodies will develop in the body.
Yes, after taking the vaccine we may experience feverishness and body aches. However, these side effects are common while taking any vaccine.
To ensure safe vaccine delivery, states have been asked to manage any kind of side effects.
In the beginning, the vaccine will be given to priority groups. However, the eligible beneficiaries will be informed with the registered mobile number regarding the health facility, place, time, and schedule for the vaccine.
The registration is mandatory for everyone. The information related to the vaccine will only be shared with the person once he/she has been registered. For the convenience of the people, the government has announced a co-win application a digital platform for the real-time monitoring of vaccines.
One of the following documents are required at the time of registration as identity proof
Photo ID is necessary for registration as well as the verification process.
Following the online registration, the beneficiary will receive the SMS on their registered mobile numbers on the due date, place, and time.
Yes, it is advisable to receive a vaccine even when you have recovered. This will build a better immune system.
People with active symptoms may carry a high risk or spread the virus at vaccination centres. And the efficacy of the vaccine is yet to be known in such a situation.
It is advisable that people with infection should defer the vaccination for at least 14days after the symptoms are resolved.
After receiving the vaccine, at least half an hour of rest is recommended. In case of any discomfort or symptoms, please inform the nearest authorities so that they can take care of it.
In that case, that individual must take the vaccine because they are at high risk.
Various phases of the trial are being undertaken to ensure efficacy and safety. So yes, the vaccine in India will be equally effective as a vaccine developed in other countries.
The vaccine in India will only be introduced after the regulatory bodies clear its safety and efficacy.